| Title XELOX FOR SALIVARY GLAND CANCERS (NCT00101075) | Dana-Farber Cancer Institute | 2004-10-01 |
| Capecitabine in Women With Operable Breast Cancer (NCT00148720) | Dana-Farber Cancer Institute | 2004-09-01 |
| CC-5013 (Lenalidomide) and Rituximab in Waldenstrom's Macroglobulinemia (NCT00142168) | Dana-Farber Cancer Institute | 2004-09-01 |
| Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies (NCT00131014) | Dana-Farber Cancer Institute | 2004-08-09 |
| Avastin and Taxotere for Esophagogastric Cancer (NCT00137813) | Dana-Farber Cancer Institute | 2004-08-01 |
| Combination Chemotherapy, Radiation Therapy and Surgery for Esophageal Cancer (NCT00165490) | Dana-Farber Cancer Institute | 2004-08-01 |
| Bortezomib in Combination With CC-5013 in Patients With Relapsed/Refractory Multiple Myeloma (NCT00153933) | Dana-Farber Cancer Institute | 2004-08-01 |
| Combination Chemotherapy and Radiation in Treating Patients With Stage III or IV Head and Neck Cancer (Paradigm Trial) (NCT00095875) | Dana-Farber Cancer Institute | 2004-08-01 |
| Preoperative Cisplatin in Early Stage Breast Cancer (NCT00148694) | Dana-Farber Cancer Institute | 2004-07-01 |
| Study of Dynavax's 1018 ISS, Following Rituxan in Patients With B-Cell Follicular Lymphoma (NCT00251394) | Dana-Farber Cancer Institute | 2004-07-01 |
| Fulvestrant in Premenopausal Women With Hormone Receptor-Positive Breast Cancer (NCT00146601) | Dana-Farber Cancer Institute | 2004-06-01 |
| Capecitabine For Nasopharyngeal Cancer (NCT00095901) | Dana-Farber Cancer Institute | 2004-06-01 |
| GM-CSF Vaccinations After Allogeneic Blood Stem Cell Transplantation in Patients With Advanced Myeloid Malignancies (NCT00426205) | Dana-Farber Cancer Institute | 2004-06-01 |
| Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate (NCT00165503) | Dana-Farber Cancer Institute | 2004-04-01 |
| Effects of Tibilone on Bone Density, Menopause Symptoms and Breast Density in Women After Prophylactic Oophorectomy (NCT00165204) | Dana-Farber Cancer Institute | 2004-04-01 |
| Monitoring of Erythroid Lineage Specific Chimerism Following Allogeneic Hematopoietic Transplantation for Thalassemia Major (NCT00480506) | Dana-Farber Cancer Institute | 2004-04-01 |
| Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma (NCT00085397) | Dana-Farber Cancer Institute | 2004-03-01 |
| Allogeneic Stem Cell Transplantation Following Chemotherapy in Patients With Hemoglobinopathies (NCT00153985) | Dana-Farber Cancer Institute | 2004-03-01 |
| Docetaxel, Estramustine and Short Term Androgen Withdrawal for Patients With a Rising PSA After Local Treatment (NCT00165399) | Dana-Farber Cancer Institute | 2004-03-01 |
| Thalidomide, Celecoxib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Malignant Glioma (NCT00047281) | Dana-Farber Cancer Institute | 2004-03-01 |
| Bevacizumab (Avastin) and Erlotinib (Tarceva) in Previously Treated Mesothelioma (NCT00137826) | Dana-Farber Cancer Institute | 2004-02-01 |
| Cardiac Screening in Survivors of Hodgkin's Disease Treated With Mediastinal Irradiation (NCT00165425) | Dana-Farber Cancer Institute | 2004-02-01 |
| Extrapleural Pneumonectomy With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Amifostine and Sodium Thiosulfate (NCT00165516) | Dana-Farber Cancer Institute | 2004-01-01 |
| Rituximab Therapy for Steroid-Refractory Chronic Graft Versus Host Disease (NCT00136396) | Dana-Farber Cancer Institute | 2004-01-01 |
| Dosimetric Analysis of Vaginal Cuff Brachytherapy in Endometrial Carcinoma (NCT00165126) | Dana-Farber Cancer Institute | 2004-01-01 |
| A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate Cancer (NCT00134706) | Dana-Farber Cancer Institute | 2004-01-01 |
| Effects of Exercise Intervention on Insulin Levels in Breast Cancer Survivors (NCT00153894) | Dana-Farber Cancer Institute | 2003-12-01 |
| Protein Tyrosine Kinases (PTK) in Multiple Myeloma (NCT00165347) | Dana-Farber Cancer Institute | 2003-12-01 |
| Bortezomib (Velcade) in Waldenstrom's Macroglobulinemia (NCT00142129) | Dana-Farber Cancer Institute | 2003-12-01 |
| Fludarabine and Rituximab for the Treatment of Marginal Zone Non-Hodgkin's Lymphoma (NCT00117156) | Dana-Farber Cancer Institute | 2003-12-01 |
| Bortezomib (Velcade) in Patients With Untreated Multiple Myeloma (NCT00153920) | Dana-Farber Cancer Institute | 2003-12-01 |
| Talotrexin in Treating Patients With Advanced or Recurrent Solid Tumors (NCT00098514) | Dana-Farber Cancer Institute | 2003-12-01 |
| Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation (NCT00144677) | Dana-Farber Cancer Institute | 2003-11-01 |
| Vaccination With Autologous, Lethally Irradiated Melanoma Cells Engineered by Adenoviral Mediated Gene Transfer to Secrete Granulocyte-Macrophage Stimulating Factor (GMSF) (NCT00809588) | Dana-Farber Cancer Institute | 2003-10-16 |
| Tarceva and Capecitabine for Pancreatic Cancer (NCT00125021) | Dana-Farber Cancer Institute | 2003-10-01 |
| Metronomic Low-Dose Cyclophosphamide and Methotrexate With or Without Bevacizumab in Treating Women With Metastatic Breast Cancer (NCT00083031) | Dana-Farber Cancer Institute | 2003-07-01 |
| Donor Dendritic Cells And Donor Lymphocytes in Patients With Relapsed Hematologic Malignancies After Allogeneic Transplant (NCT00476177) | Dana-Farber Cancer Institute | 2003-07-01 |
| Polyunsaturated Fatty Acids in Treating Patients With Prostate Cancer Undergoing Prostate Biopsy and/or Surgery (NCT00458549) | Dana-Farber Cancer Institute | 2003-05-27 |
| Amifostine for Head and Neck Irradiation in Lymphoma (NCT00136474) | Dana-Farber Cancer Institute | 2003-05-01 |
| Randomized Amifostine For SCCHN (NCT00095927) | Dana-Farber Cancer Institute | 2003-05-01 |
| Educational Interventions for Patients With DCIS (NCT00148655) | Dana-Farber Cancer Institute | 2003-05-01 |
| Preventing Adverse Drug Events With PatientSite (NCT00140504) | Dana-Farber Cancer Institute | 2003-04-01 |
| Phase II Study of Campath-1H Antibody to Treat Waldenstrom's Macroglobulinemia (NCT00142181) | Dana-Farber Cancer Institute | 2003-03-01 |
| Two Doses of Conjugated Estrogen (Premarin) in Patients With Androgen-Independent Prostate Cancer (NCT00134654) | Dana-Farber Cancer Institute | 2003-03-01 |
| Tarceva, Capecitabine and Oxaliplatin for Metastatic Colorectal Cancer (NCT00123851) | Dana-Farber Cancer Institute | 2003-03-01 |
| Natural History Study of Patients With Chronic Myelogenous Leukemia (NCT00429910) | Dana-Farber Cancer Institute | 2003-02-01 |
| Study of Gemcitabine and Vinorelbine in Soft Tissue Sarcomas (NCT00134641) | Dana-Farber Cancer Institute | 2003-02-01 |
| Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT (NCT00084838) | Dana-Farber Cancer Institute | 2003-02-01 |
| Study of OSI-774 (Tarceva) in Previously Untreated Elderly Lung Cancer Patients (NCT00137800) | Dana-Farber Cancer Institute | 2003-02-01 |
| rhEndostatin Protein Involving Pediatric Patients With Cancer (NCT00165373) | Dana-Farber Cancer Institute | 2003-01-01 |
| High Dose Rate Intracavitary Brachytherapy as the Sole Method of Radiation Therapy for Breast Carcinoma (NCT00165581) | Dana-Farber Cancer Institute | 2002-12-01 |
| Celecoxib (Celebrex) Versus Placebo in Men With Recurrent Prostate Cancer (NCT00136487) | Dana-Farber Cancer Institute | 2002-10-01 |
| Thalidomide and Temozolomide in Relapsed or Progressive CNS Disease or Neuroblastoma (NCT00098865) | Dana-Farber Cancer Institute | 2002-09-01 |
| Tacrolimus, Sirolimus and Methotrexate as Graft Versus Host Disease Prophylaxis After Blood Stem Cell Transplantation (NCT00146614) | Dana-Farber Cancer Institute | 2002-07-01 |
| Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation (NCT00144703) | Dana-Farber Cancer Institute | 2002-07-01 |
| Gemcitabine and Cisplatin for Gallbladder and Biliary Tract Cancer (NCT00123825) | Dana-Farber Cancer Institute | 2002-07-01 |
| Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia (NCT00052611) | Dana-Farber Cancer Institute | 2002-06-01 |
| A Study in Adults With Untreated Acute Lymphoblastic Leukemia (NCT00136435) | Dana-Farber Cancer Institute | 2002-06-01 |
| Thalidomide in Combination With Temodar in Patients With Neuroendocrine Tumors (NCT00165230) | Dana-Farber Cancer Institute | 2002-05-01 |
| A Study of Gleevec in Patients With Idiopathic Myelofibrosis or Chronic Myelomonocytic Leukemia (CMML) (NCT00136409) | Dana-Farber Cancer Institute | 2002-05-01 |
| Navelbine and Capecitabine in the Treatment of Metastatic Breast Cancer (NCT00153907) | Dana-Farber Cancer Institute | 2002-03-01 |
| Letrozole in Preventing Breast Cancer in Postmenopausal Women (NCT00090857) | Dana-Farber Cancer Institute | 2002-02-01 |
| Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal Cancer (NCT00137852) | Dana-Farber Cancer Institute | 2002-01-01 |
| Correlation of FC Gamma RIIIA Receptor Response in Patients With Waldenstrom's Macroglobulinemia (NCT00142155) | Dana-Farber Cancer Institute | 2002-01-01 |
| Epirubicin and Thalidomide in Treating Patients With Liver Cancer (NCT00058487) | Dana-Farber Cancer Institute | 2001-12-01 |
| Capecitabine and Thalidomide in Previously Treated Metastatic Colorectal Carcinoma (NCT00165217) | Dana-Farber Cancer Institute | 2001-11-01 |
| Capecitabine or 5-Fluorouracil in Combination With Irinotecan and Cisplatin in Patients With Solid Tumor Malignancies (NCT00215501) | Dana-Farber Cancer Institute | 2001-11-01 |
| Pulmonary Function in Patients With Hodgkin's Disease Receiving Bleomycin-Based Chemotherapy (NCT00165438) | Dana-Farber Cancer Institute | 2001-10-01 |
| Prolonged Daily Temozolomide for Low-Grade Glioma (NCT00165360) | Dana-Farber Cancer Institute | 2001-09-01 |
| Trastuzumab in Combination With Vinorelbine or Taxane-Based Chemotherapy in Patients With Metastatic Breast Cancer (NCT00146549) | Dana-Farber Cancer Institute | 2001-08-01 |
| Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer (NCT00165464) | Dana-Farber Cancer Institute | 2001-08-01 |
| MRI-guided Bone Marrow Biopsies of Prostate Cancer Patients (NCT00165386) | Dana-Farber Cancer Institute | 2001-07-01 |
| A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive Cancer (NCT00165451) | Dana-Farber Cancer Institute | 2001-06-01 |
| Preoperative Herceptin and Navelbine for Breast Cancer (NCT00148681) | Dana-Farber Cancer Institute | 2001-05-01 |
| Prostate Immobilization Device Used During Radiation Treatments to Decrease Rectal Bleeding (NCT00114985) | Dana-Farber Cancer Institute | 2001-04-01 |
| Tamoxifen in the Prevention of Breast Cancer in Hodgkin's Disease Survivors (NCT00165308) | Dana-Farber Cancer Institute | 2001-04-01 |
| Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme (NCT00047294) | Dana-Farber Cancer Institute | 2001-04-01 |
| Inhaled Morphine Compared With Morphine By Mouth in Treating Cancer Patients With Breakthrough Pain (NCT00020618) | Dana-Farber Cancer Institute | 2001-03-01 |
| Vaccine Therapy in Treating Patients With Acute Lymphoblastic Leukemia (NCT00020670) | Dana-Farber Cancer Institute | 2001-02-20 |
| Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host Disease (NCT00053976) | Dana-Farber Cancer Institute | 2001-01-01 |
| Valdecoxib in Treating Chronic Pain in Cancer Patients (NCT00021996) | Dana-Farber Cancer Institute | 2001-01-01 |
| Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor (NCT00069940) | Dana-Farber Cancer Institute | 2000-12-01 |
| Treatment of Acute Lymphoblastic Leukemia in Children (NCT00165178) | Dana-Farber Cancer Institute | 2000-09-01 |
| Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma (NCT00215514) | Dana-Farber Cancer Institute | 2000-09-01 |
| Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer (NCT00006107) | Dana-Farber Cancer Institute | 2000-07-14 |
| Vinorelbine in Unresectable or Metastatic Esophageal and Gastric Adenocarcinoma (NCT00215462) | Dana-Farber Cancer Institute | 2000-06-01 |
| Naloxone in Treating Constipation in Patients Who Are Receiving Opioids for Chronic Pain (NCT00020605) | Dana-Farber Cancer Institute | 2000-05-01 |
| Phase I Study of Amifostine in Patients With Bone Marrow Failure Related to Fanconi's Anemia (NCT00006127) | Dana-Farber Cancer Institute | 2000-04-01 |
| Defibrotide in Treating Patients With Liver Damage Following Peripheral Stem Cell Transplantation (NCT00003966) | Dana-Farber Cancer Institute | 2000-04-01 |
| Bone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous Therapy (NCT00005988) | Dana-Farber Cancer Institute | 2000-02-01 |
| Dynamic Area Telethermometry (DAT) as an Imaging Modality in Patients With Cancer (NCT00165100) | Dana-Farber Cancer Institute | 2000-01-01 |
| Study of Vaccination With Autologous Acute Myeloblastic Leukemia Cells in Patients With Advanced Myelodysplasia or Acute Myelogenous Leukemia (NCT00136422) | Dana-Farber Cancer Institute | 2000-01-01 |
| Docetaxel in Treating Patients With Stage II or Stage III Prostate Cancer (NCT00005096) | Dana-Farber Cancer Institute | 1999-12-01 |
| Rosiglitazone in Treating Patients With Liposarcoma (NCT00004180) | Dana-Farber Cancer Institute | 1999-10-01 |
| Trastuzumab in Treating Patients With Advanced Salivary Gland Cancer (NCT00004163) | Dana-Farber Cancer Institute | 1999-10-01 |
| Understanding Chronic Lymphocytic Leukemia (NCT04028531) | Dana-Farber Cancer Institute | 1999-09-29 |
| Taxotere, Cisplatin, and CPT-11 in Advanced Solid Tumor Malignancies (NCT00251407) | Dana-Farber Cancer Institute | 1999-09-01 |
| Combination Chemotherapy in Treating Patients With Stage IIB, Stage III, or Stage IV Cancer of the Nasopharynx (NCT00004164) | Dana-Farber Cancer Institute | 1999-08-01 |
| Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma (NCT00165555) | Dana-Farber Cancer Institute | 1999-08-01 |
| Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck Cancer (NCT00004070) | Dana-Farber Cancer Institute | 1999-07-01 |